Mergers & AcquisitionsBy The Online Investor Staff, updated Sat., Sep. 19, 8:43 AM
|This Slide: #40 of 100|
Slide #40. Reign Resources Corporation — Sigyn Therapeutics, Inc.
Reign Resources Corporation (RGNP)
Sigyn Therapeutics, Inc.
Reign Resources Corporation ("Reign") (OTCMARKETS: RGNP, RGNPD) announced today that the Company has approved a share exchange agreement with Sigyn Therapeutics, Inc., a privately held medical technology company focused on the treatment of life-threatening inflammatory conditions. As reported in a Schedule 14C Information statement filed today with the U.S. Securities and Exchange Commission (SEC) and a Form 8-K filed on August 31, 2020, Reign resources will acquire all of the outstanding capital stock of Sigyn Therapeutics in exchange for shares of Reign common stock representing approximately 75 percent of Reign's outstanding common stock. The Schedule 14C Information statement and Form 8-K can be accessed at www.SEC.gov.